Lupin Limited has informed the Exchange about press release dated 04-Oct-2022 titled Lupin Receives Approval from U.S. FDA for Darunavir Tablets.
Lupin Limited has informed the Exchange about press release dated 04-Oct-2022 titled Lupin Receives Approval from U.S. FDA for Darunavir Tablets.